China Biotech In Review: Eli Lilly Joins The Big Pharmas Accused Of Bribing In China

Home › China Biotech In Review: Eli Lilly Joins The Big Pharmas Accused Of Bribing In China

MicuRx Pharmaceuticals, a San Francisco-Shanghai antibiotics company, raised $25 million in Series B financing.

24.09	Hurricane John Graphics
24.09	Summary for Hurricane John (EP5/EP102024)
24.09	Hurricane John Public Advisory Number 6A
24.09	Potential Tropical Cyclone Nine Public Advisory Number 2A
24.09	Summary for Potential Tropical Cyclone Nine (AT4/AL092024)
24.09	CrowdStrike: Company to face questions over global IT outage
24.09	Tigers and crocs make mangrove preservation tough work
24.09	Atlantic Tropical Weather Outlook
More »

je.st